Literature DB >> 23255938

Elevated preoperative plasma D-dimer levels and the incidence of venous thromboembolism in Japanese females with gynecological cancer.

Junichi Kodama1, Noriko Seki, Chikako Fukushima, Tomoyuki Kusumoto, Keiichiro Nakamura, Atsushi Hongo, Yuji Hiramatsu.   

Abstract

The purpose of the present study was to determine the incidence of increased levels of D-dimer and associated factors in preoperative patients with gynecological cancer. Furthermore, we determined the incidence and risk factors associated with preoperative venous thromboembolism (VTE). Overall, 456 patients with invasive gynecological cancer scheduled to undergo surgery were recruited. Preoperative plasma D-dimer levels were measured and patients whose plasma D-dimer concentration exceeded the pre-set cut-off value underwent computed tomography scanning. The incidence of elevated D-dimer and VTE was identified as significantly higher in patients with ovarian cancer. Multivariate analysis revealed that advanced age, low hemoglobin levels and elevated C-reactive protein (CRP) levels were independent factors for preoperative elevations in plasma D-dimer levels. Advanced age was an independent risk factor for preoperative VTE. Massive ascites and the presence of co-morbidities were independent risk factors for preoperative VTE in ovarian cancer. Advanced age and stage were independent risk factors for preoperative VTE in endometrial cancer. Advanced age was an independent risk factor for preoperative VTE in cervical cancer. Plasma D-dimer levels and the incidence of preoperative VTE were higher in patients with ovarian cancer compared with those with other gynecological cancers. Advanced age, low hemoglobin levels and elevated CRP levels were significant factors associated with elevated plasma D-dimer levels and age was an independent risk factor for preoperative VTE in gynecological cancer.

Entities:  

Year:  2012        PMID: 23255938      PMCID: PMC3525512          DOI: 10.3892/ol.2012.970

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Authors:  Hideki Nomura; Hideo Wada; Toshiro Mizuno; Naoyuki Katayama; Yasunori Abe; Maki Noda; Kaname Nakatani; Takeshi Matsumoto; Satoshi Ota; Norikazu Yamada; Akihiro Sudo; Atsumasa Uchida; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-02-19       Impact factor: 2.490

2.  Age-dependent effect on the level of factor IX.

Authors:  J D Sweeney; L A Hoernig
Journal:  Am J Clin Pathol       Date:  1993-06       Impact factor: 2.493

3.  Risk factors for venous thromboembolic events in cancer patients.

Authors:  K Kröger; D Weiland; C Ose; N Neumann; S Weiss; C Hirsch; K Urbanski; S Seeber; M E Scheulen
Journal:  Ann Oncol       Date:  2005-11-09       Impact factor: 32.976

Review 4.  The relationship between ABO histo-blood group, factor VIII and von Willebrand factor.

Authors:  J O'Donnell; M A Laffan
Journal:  Transfus Med       Date:  2001-08       Impact factor: 2.019

5.  Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal cancer treated with chemotherapy, radiation, and erythropoeitin.

Authors:  Amy Lin; Janice Ryu; Danielle Harvey; Barbara Sieracki; Sidney Scudder; Ted Wun
Journal:  Gynecol Oncol       Date:  2006-01-10       Impact factor: 5.482

Review 6.  Elevated clotting factor levels and venous thrombosis.

Authors:  Rogier M Bertina
Journal:  Pathophysiol Haemost Thromb       Date:  2003 Sep-2004 Dec

Review 7.  Venous thromboembolism in cervical cancer.

Authors:  Lisa Barbera; Gillian Thomas
Journal:  Lancet Oncol       Date:  2008-01       Impact factor: 41.316

Review 8.  Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review.

Authors:  M Heather Einstein; Elizabeth A Pritts; Ellen M Hartenbach
Journal:  Gynecol Oncol       Date:  2007-04-20       Impact factor: 5.482

9.  Fibrin fragment D-dimer and the risk of future venous thrombosis.

Authors:  Mary Cushman; Aaron R Folsom; Lu Wang; Nena Aleksic; Wayne D Rosamond; Russell P Tracy; Susan R Heckbert
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  High incidence of silent venous thromboembolism before treatment in ovarian cancer.

Authors:  T Satoh; A Oki; K Uno; M Sakurai; H Ochi; S Okada; R Minami; K Matsumoto; Y O Tanaka; H Tsunoda; S Homma; H Yoshikawa
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

View more
  4 in total

Review 1.  Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma.

Authors:  Ryo Tamura; Kosuke Yoshihara; Takayuki Enomoto
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

2.  The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis.

Authors:  Lu Ye; Li Cai; Yonghui Fu; Debao Zhuang; Xiaoqing Hu; Youkun Jie
Journal:  World J Surg Oncol       Date:  2021-01-13       Impact factor: 2.754

3.  Incidence and risk of venous thromboembolism according to primary treatment type in women with endometrial cancer: a population-based study.

Authors:  Jin-Sung Yuk; Banghyun Lee; Kidong Kim; Myoung Hwan Kim; Yong-Soo Seo; Sung Ook Hwang; Yong Kyoon Cho; Yong Beom Kim
Journal:  BMC Cancer       Date:  2021-10-30       Impact factor: 4.430

4.  Postoperative decreased levels of D-dimer in patients with gynecologic cancer with enoxaparin and fondaparinux thromboprophylaxis.

Authors:  Junichi Kodama; Noriko Seki; Chikako Fukushima; Tomoyuki Kusumoto; Keiichiro Nakamura; Yuji Hiramatsu
Journal:  Mol Clin Oncol       Date:  2013-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.